AMRZ · Amrize
5 filings
AMRZ 10-Q Quarterly Reports
Amrize - 5 quarterly reports
AMRZ filed 1 annual reports (10-K), 5 quarterly reports (10-Q) and 20 current reports (8-K) between 2025 and 2026.
- 8-K · Jun 2, 2025
- 8-K · Jun 3, 2025
- 8-K · Jun 18, 2025
- 8-K · Jun 23, 2025
- 8-K · Aug 6, 2025
- 10-Q · Aug 7, 2025
- 8-K · Oct 28, 2025
- 10-Q · Oct 29, 2025
- 8-K · Jan 22, 2026
- 8-K · Feb 9, 2026
- 8-K · Feb 12, 2026
- 8-K · Feb 17, 2026
- 10-K · Feb 18, 2026
- 8-K · Feb 20, 2026
- 8-K · Mar 31, 2026
- 8-K · Apr 14, 2026
- 8-K · Apr 21, 2026
- 8-K · Apr 29, 2026
- 10-Q · May 7, 2026
- 8-K · Aug 6, 2026
- 10-Q · Aug 10, 2026
- 8-K · Aug 24, 2026
- 8-K · Sep 1, 2026
- 8-K · Sep 11, 2026
- 8-K · Oct 28, 2026
- 10-Q · Oct 29, 2026
- 2026-Q3Oct 29, 2026
Amrize Quarterly Report for Q3 Ended Sep 30, 2026
Amrize Ltd. (AMRZ) reported solid revenue growth for the nine months ended September 30, 2026, with a 5.0% increase to $9.445 billion, driven by volume growth, acquisitions, and price increases. Net income also saw a healthy rise of 7.7% to $927 million for the same period. The company's Building Materials segment continues to be the larger contributor to revenue and showed robust growth, while the Building Envelope segment experienced a decline in Segment Adjusted EBITDA despite revenue growth. A key concern for investors is the significant decrease in cash and cash equivalents, dropping from $1.922 billion at the start of the year to $299 million by September 30, 2026, coupled with a substantial negative free cash flow of $(551) million for the nine-month period. This was largely due to increased investing activities, particularly acquisitions and capital expenditures, and significant share repurchases and dividend payments. The company faces ongoing risks related to inflationary pressures, supply chain disruptions, and a previously disclosed material weakness in internal controls over financial reporting, although remediation efforts are underway.
- 2026-Q2Aug 10, 2026
Amrize Quarterly Report for Q2 Ended Jun 30, 2026
Amrize Ltd (AMRZ) reported a strong second quarter and first half of 2026, demonstrating robust revenue growth and improved profitability. For the three months ended June 30, 2026, revenues increased by 8.6% to $3,494 million, driven by volume growth and contributions from acquisitions. Net income saw a significant jump of 14.6% to $478 million, or $0.86 per diluted share. The company also improved its net income margin to 13.6%. For the six months ended June 30, 2026, revenues grew by 6.9% to $5,675 million, with net income attributable to the Company increasing by 15.5% to $373 million. The company's strategic focus on its Building Envelope segment, alongside continued strength in Building Materials, appears to be driving positive financial performance. Despite some cost pressures, including higher raw material and distribution costs, Amrize managed these effectively, resulting in enhanced profitability. The company also reported progress in its transition to a standalone entity following its spin-off from Holcim in June 2025. Financially, Amrize maintained a solid balance sheet, though cash and cash equivalents decreased significantly from $1,922 million at the end of 2025 to $729 million at the end of the second quarter of 2026, primarily due to operating and investing activities. The company also actively repurchased shares during the quarter, signaling confidence in its valuation. Investors should note the company's ongoing efforts to manage costs and integrate acquisitions, which are key to sustaining this positive momentum.
- 2026-Q1May 7, 2026
Amrize Quarterly Report for Q1 Ended Mar 31, 2026
Amrize Ltd (AMRZ) reported a weaker first quarter of 2026 on a standalone basis, with a net loss attributable to the Company of $116 million, or $(0.21) per share, versus a $87 million loss ($(0.16) per share) a year earlier. Revenue rose 4.7% to $2,178 million, driven by volume growth in Building Materials (up 12.9%, including the PB Materials acquisition), but Adjusted EBITDA fell 10.3% to $192 million and Adjusted EBITDA margin contracted to 8.8% from 10.3%. Building Envelope was the main drag: segment revenue fell 9.8% and segment Adjusted EBITDA fell 37.1% on lower prices, lower volumes, a temporary plant disruption and higher warranty accruals. Standalone corporate costs also rose $26 million, and SG&A increased 22.2%. Interest expense fell 40.7% to $70 million as related-party debt was retired after the spin-off. Cash flow was seasonally negative, with operating cash outflow of $896 million and free cash flow of $(1,163) million, compared with $(1,065) million a year earlier. Investing outflows included the $425 million PB Materials acquisition. Cash fell to $1,099 million, and short-term commercial paper borrowings of $777 million were drawn to fund the working-capital build. Management's disclosure controls were concluded to be not effective because of a previously reported material weakness in internal control over financial reporting, tied to insufficient U.S. GAAP accounting personnel. Remediation is ongoing, and the company implemented a new financial consolidation system on January 1, 2026. Shareholder-return actions are notable after quarter-end. Shareholders approved a $0.44 per share special dividend, paid May 4, 2026, and up to $0.44 per share in ordinary annual dividends, the first installment being $0.11 per share payable May 20, 2026. The Board also authorized a $1.0 billion share repurchase program with a 12-month term. Given the seasonal pattern of the business, investors will want to watch whether the second and third quarters restore earnings and cash generation, and whether the material weakness is remediated.
- 2025-Q3Oct 29, 2025
Amrize Quarterly Report for Q3 Ended Sep 30, 2025
Amrize Ltd (AMRZ) reported its financial results for the period ending September 30, 2025. The company experienced a modest increase in revenue for both the three and nine-month periods compared to the prior year, driven primarily by higher sales volumes and price increases, although offset by foreign currency headwinds. However, net income attributable to the company saw a slight decrease in both periods. A significant event for Amrize Ltd was its separation from Holcim Ltd., a process completed in June 2025, which resulted in Amrize becoming an independent, publicly traded company. This separation involved substantial financial activities, including debt issuances and exchanges, aimed at establishing the company's independent capital structure. Despite the operational scale and market presence in North America across building materials and building envelope segments, the company is navigating increased selling, general, and administrative expenses due to the costs associated with becoming a standalone entity, as well as higher litigation-related costs.
- 2025-Q2Aug 7, 2025
Amrize Quarterly Report for Q2 Ended Jun 30, 2025
Amrize Ltd (AMRZ) reported its financial results for the period ending June 30, 2025, marked by its recent separation from Holcim Ltd and transition to an independent public company. The company experienced a slight decrease in revenues for both the three and six-month periods compared to the prior year, primarily due to lower sales volumes in the Building Materials segment, partially offset by price increases and acquisitions. While gross profit saw a marginal decline, selling, general, and administrative expenses increased significantly, largely attributed to costs associated with the spin-off and establishing standalone operations. Net income and Adjusted EBITDA both declined year-over-year, reflecting the impact of increased operating expenses and challenging market conditions, including adverse weather and softness in residential markets. Despite these headwinds, Amrize continues to invest in strategic growth areas like its Building Envelope segment and aggregates business, and has actively managed its capital structure through new debt issuances and a debt-for-debt exchange. The company is also focused on remediating a previously disclosed material weakness in internal controls over financial reporting, a critical step for a newly public entity.